Park Ha Biological Technology Co., Ltd. is trading at $1.41 (6% down) in pre-market sessions following the closure of a $2.0 million registered direct stock offering.
- The capital raise marks the company's second equity offering this year, intensifying investor concerns regarding ongoing share dilution.
- Shares continue to face downward pressure after an initial decline triggered during yesterday's after-hours trading session.